अApnaFunda

ORKLA INDIA LIMITED (ORKLAINDIA)

Consumer Non-Durables · Food: Major Diversified · figures to Nov '26

Quality scoreHow the business itself ranks against its sector peers on profitability, 3-year growth and leverage. 50 is the middle of the sector.82 / 100
Profitability 64Balance sheet 100
Momentum scoreHow strong the recent trend is: 3-month price change, 12-month improvement in earnings and the rise in FII + DII holding, among companies above ₹500 cr.55 / 100
Price 63Earnings 46

Share price

Closing priceAdjusted for splits and bonus issues.

₹560.3 latest close · −7.8% over the last 90 sessions

₹500₹550₹600Jul 3Jul 29Aug 24Sep 17Oct 14Nov 9 ₹500₹550₹600Jul 3Sep 4Nov 9

₹560.3 month-end · −13.6% over 12 months

₹550₹600₹650Nov '25Jan '26Apr '26Jun '26Sep '26Nov '26 ₹550₹600₹650Nov '25May '26Nov '26

52-week range ₹503.50 to ₹760.00 · 1-year volatility 28.2%

Was the rally earned?

-14%share price, 1 yearLower P/E held it back

Earnings helped, the multiple did not.

  • Per-share earnings added 9 points, but investors now pay less per rupee of profit (P/E 33.4x to 26.1x), which took 23 points back.
  • The share count barely moved.
Net profit growth: +10 pts. Points of the price return explained by net profit growing (or shrinking).+10 ptsNet profit growthP/E change: −23 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−23 ptsP/E changeShare count change: −1 pts. Points of the price return explained by the share count changing. More shares count against the price.−1 ptsShare count changeShare price: −14%−14%Share priceNet profit growth: +10 pts. Points of the price return explained by net profit growing (or shrinking).+10ProfitP/E change: −23 pts. Points of the price return explained by the market paying a higher or lower P/E multiple.−23P/EShare count change: −1 pts. Points of the price return explained by the share count changing. More shares count against the price.−1SharesShare price: −14%−14%Share price
Net profit growth+10 ptsNet profit rose about 12%, which lifts the price.
P/E change-23 ptsThe P/E fell from 33.4x to 26.1x, which lowers the price.
Share count change-1 ptsShare count was little changed. More shares would count against the price.
What do "pts" mean?

"pts" are percentage points of the share price return. The parts add up to the total shown for each period. Because price = P/E × net profit ÷ share count, higher profit pushes the price up, a higher P/E pushes it up, and more shares push it down.

Example: if the price rose 34% and profit growth accounts for +58 pts while a lower P/E accounts for -24 pts, then 58 - 24 = 34. The +58 is not the profit growth rate itself: it is the part of the price move that profit growth explains.

Not shown for 3 years and 5 years: earnings were negative at one end, or there is not enough history.

Net profit is trailing twelve months as reported with a 60-day lag.

Compare this with NESTLE INDIA

How rough has the ride been?

Maximum drawdown-28.7%not yet recovered
1-year volatility28.2%annualised
Volume spikes4last 90 sessions, 5x the 50-day median

Drawdown from peak

0%−10%−20%2026−26.4% 0%−10%−20%2026−26.4%
Largest drawdowns

-28.7% (2025-11 peak to 2026-10 low, not yet recovered)

Most recent volume spikes

2026-11-05: 11.3x the 50-day median, price +8.3% that day

2026-08-27: 5.8x the 50-day median, price +4.5% that day

2026-08-10: 6x the 50-day median, price +0.2% that day

Where does it rank among Consumer Non-Durables peers?

Each cell is the company's percentile rank among its Consumer Non-Durables peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).

Where it ranks today

  • ROCE59th▲ 4 pts vs a year ago
  • Op. margin70th▼ 8 pts vs a year ago
  • Revenue growth43rd
  • EPS growth48th
  • Debt/equity ↓88thflat vs a year ago
  • Cash cycle ↓79thflat vs a year ago
  • P/E ↓51stflat vs a year ago
  • 12M momentum54th

Rank history

ROCE
Op. margin
Revenue growth
EPS growth
Debt/equity ↓
Cash cycle ↓
P/E ↓
12M momentum
Dec '21Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25Jan '26Jul '26Nov '26
Lower rank Higher rank Not enough data

Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.

The Consumer Non-Durables sector page Watch it move against Consumer Non-Durables in the Observatory

What is the price implying?

~21%annual earnings growth implied by the priceIn line with delivered growth

At normalised P/E (five-year average earnings) of 31.4x, a holder earning 12%/yr needs earnings to grow about 20.6%/yr for 10 years, then trade at 15x.

Delivered20.2%/yrEPS, last 7 fiscal years · 3-yr avg to 3-yr avg
Gap+0.4 ptsimplied minus delivered
Rank517thmost demanding of 856

Over time

Implied growth by month (solid) and delivered growth (dashed).

0%17%33% Jun 2025Nov 2026 0%17%33% Jun 2025Nov 2026

Change the assumptions

Exit P/E / return11%12%13%
12x22.2%23.3%24.4%
15x19.5%20.6%21.7%
20x16.1%17.2%18.2%

Drag a slider to test other assumptions

Implied: 20.6%/yr

“Implied growth” is what the current price would require under our stated assumptions, not what we expect. How this is calculated and the market-wide lists.

What prices imply across Consumer Non-Durables The market-wide Expectations lists

Key figures

Share Priceclose 9 Nov
₹560.30
P/E
26.1x
ROCE
15.0%
Market Cap
₹7671 cr
Revenue (TTM)
₹2571 cr
P/S
3.0x
P/B
2.8x
ROE
10.7%
Operating Margin
17.0%
Debt / Equity
0.0x
Promoter Holding
75.0%
12M Momentum
-13.6%

52-week range

₹503.50₹760.00
22% of the way from its 52-week low to its high

Price risk

1Y volatility
28.2%
Beta vs sector
1-year daily
0.54

Balance sheet & cash

Interest cover
operating profit ÷ interest
50.0x
Cash from profit, 3Y
operating cash flow ÷ net profit
1.24x
Share count, 1Y
unchanged

Are profits backed by cash?

5 of 5checks within rangeAll clear
Other income reliance9%Within range

Other income as a share of pre-tax profit (trailing twelve months): 8.9%. Bands: below 15%, 15% to 35%, above 35%.

Tax rate25%Within range

Median quarterly effective tax rate over about 2.5 years: 25.0%. Bands: 15% to 35%, 5% to 15% or 35% to 50%, outside 5% to 50%.

Cash conversion1.24xWithin range

Operating cash flow divided by net profit over the last three fiscal years: 1.24x (cash from operations ₹949 cr, net profit ₹768 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.

Free cash flow5 of 5 yrsWithin range

Fiscal years with positive free cash flow in the last 5: 5. Bands: at least 80% of years, 40% to 80%, below 40%.

Receivable days vs history—Not enough data

Not enough reported data to compute this.

Capital work in progress0% of fixed assetsWithin range

Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.

Payable days—Not enough data

Not enough reported data to compute this.

Tap a check to see how it is measured

How to read this

Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.

All terms explained in the glossary →

What happened next to similar setups

−3.0%typical 12-month return vs the marketNot meaningfully different from the base rate
  • We found 50 past situations where a non-financial company looked like ORKLA INDIA LIMITED today on valuation, return on capital, margins, debt, growth, price momentum, size and volatility.
  • Over the following 12 months the middle half of them returned −20% to +17% vs the market, against −4% for all non-financial companies in the same months.
  • The gap against the base rate (+0.6%, 80% range −11.6% to +2.8%) is within what chance and overlapping periods produce.

Where the 50 outcomes landed

−50%0%+50%+100%
WHIRLPOOL · Mar 2023: −37.5% vs market
TTKPRESTIG · Feb 2023: −33.8% vs market
DEEPAKNTR · Jan 2025: −33.4% vs market
EXIDEIND · Jul 2020: −26.7% vs market
CERA · Oct 2025: −25.2% vs market
GALAXYSURF · Feb 2025: −24.2% vs market
KANSAINER · Feb 2025: −23.9% vs market
IPCALAB · Jul 2022: −23.9% vs market
WONDERLA · Mar 2020: −23.4% vs market
CROMPTON · Jun 2025: −22.8% vs market
FINCABLES · Jan 2020: −22.6% vs market
SUNDRMFAST · Feb 2025: −20.8% vs market
GARFIBRES · May 2023: −20.3% vs market
ADVENZYMES · May 2024: −20.0% vs market
NOCIL · Jan 2024: −19.9% vs market
CONCOR · Oct 2025: −19.8% vs market
AVANTIFEED · Sep 2022: −18.8% vs market
MAYURUNIQ · Nov 2023: −14.6% vs market
RATNAMANI · Jun 2025: −14.5% vs market
VINATIORGA · Jan 2025: −14.0% vs market
STARCEMENT · May 2020: −13.6% vs market
ESCORTS · Jul 2025: −12.8% vs market
INDIGOPNTS · Jul 2025: −12.1% vs market
BALMLAWRIE · Feb 2020: −11.4% vs market
FLAIR · Jun 2025: −3.1% vs market
ATUL · Sep 2025: −2.9% vs market
VESUVIUS · Jul 2020: −2.6% vs market
ENDURANCE · Feb 2023: −0.4% vs market
KAJARIACER · May 2025: +0.9% vs market
ARE&M · Feb 2023: +1.2% vs market
VGUARD · May 2023: +2.8% vs market
BOSCHLTD · Sep 2022: +3.6% vs market
FINPIPE · Aug 2020: +4.4% vs market
ACC · Sep 2021: +6.8% vs market
CIPLA · Apr 2024: +9.0% vs market
FDC · Jan 2023: +13.0% vs market
SASKEN · Feb 2020: +14.7% vs market
DODLA · May 2023: +17.5% vs market
VSTTILLERS · Jun 2025: +22.8% vs market
AJANTPHARM · Aug 2023: +27.5% vs market
KSB · May 2021: +28.4% vs market
AMBUJACEM · Sep 2021: +28.4% vs market
GPPL · Nov 2022: +35.5% vs market
GLAND · Jun 2025: +35.8% vs market
CUMMINSIND · Dec 2021: +41.4% vs market
JBCHEPHARM · Aug 2022: +44.0% vs market
RAILTEL · Oct 2022: +74.2% vs market
CARBORUNIV · Oct 2020: +85.0% vs market
BAJAJCON · Jul 2025: +122.9% vs market
PERSISTENT · Apr 2020: +168.9% vs market
Similar setups −3.0%All companies −3.6%← worse than the marketbetter than the market →

Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 2 beyond the range shown, drawn at the edge

Similar setups' median
−3.0%
All companies' median
−3.6%
Beat the market
44% vs 46%

50 past situations · 50 companies · 32 months · 2020–2025

The closest matches

CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
FDC
Health Technology
Jan 2023 21x15% −9%−16% +13%
CARBORUNIV
Process Industries
Oct 2020 20x18% −11%−18% +85%
STARCEMENT
Producer Manufacturing
May 2020 10x18% −39%−43% −14%
ADVENZYMES
Consumer Non-Durables
May 2024 38x12% +32%−13% −20%
INDIGOPNTS
Process Industries
Jul 2025 40x19% −20%−29% −12%
Show the other 3 matches
CompanyWhenP/EROCE12M mom.DrawdownNext 12 months
KSB
Producer Manufacturing
May 2021 36x18% +111%−5% +28%
DEEPAKNTR
Process Industries
Jan 2025 37x22% +1%−25% −33%
CONCOR
Transportation
Oct 2025 32x14% −20%−21% −20%
How reliable is this?

Matched on P/E, P/S, ROCE, operating margin, debt/equity, interest cover, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: 12-month momentum, drawdown from 12-month high and revenue growth. One match per company and at most 7 from any one month.

Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.

How this is built

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to ORKLA INDIA LIMITED. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

Methodology

How historical analogs are built

Data as of 2026-11-09. Outcome pool: Jan 2020 to Oct 2025.

For every company we look at the situation it is in today (valuation, return on capital, margins, debt, growth, 12-month price momentum, drawdown, size and volatility) and find past company-months that looked most like it. We then show what happened to those past situations over the following 12 months, measured against the ApnaFunda All index and against the base rate. It describes history. It does not predict anything.

What is compared

FeatureWeightNon-financialFinancial
P/E1yesyes
P/S1yes—
P/B1—yes
ROCE1yes—
operating margin1yes—
ROE1—yes
debt/equity0.75yes—
interest cover0.5yes—
revenue growth0.75yesyes
12-month momentum1yesyes
drawdown from 12-month high0.75yesyes
size0.75yesyes
volatility0.5yesyes

Weights were set by judgement before any outcome was looked at and are never tuned on results. Loss-making companies (negative P/E or net profit) are only matched with other loss-making companies. Banks, NBFCs and insurers are compared only with each other and use a different feature set. Every feature is converted, month by month, to its rank among companies in the same pool in that month, so a P/E of 30 in a hot market and a P/E of 22 in a cold one can match if both were equally expensive for their time. Only that month's data is used.

How closeness and the sample are defined

Distance is the weighted root-mean-square gap between the standardised features both companies have. A match needs at least 70% of the query's feature weight, a distance of at most 0.9, and 30 matches at minimum to be shown. We keep up to 50 matches with these exclusions: never the company itself, one match per company (its closest month), and at most 7 from any one calendar month so a single market episode cannot dominate.

Base rate

The base rate is the distribution of 12-month returns, relative to the market, of every eligible company-month in the same pool, with each month weighted to match the months the analogs came from. It answers: how did a random company do in these same months? Because matches from nearby months share the same market conditions, we also report the number of distinct 12-month windows behind a result, and a bootstrap that resamples months decides whether the analog median differs from the base rate at all. "Not meaningfully different" is the usual outcome and the page copy is written for it.

Limits you should know

  • One market period. The outcome pool covers 2020–2025 only (70 months), including the 2020 crash and the 2020–21 rally.
  • Survivorship. Only companies listed today are included. Delisted and bankrupt companies are missing, which flatters past outcomes, particularly for distressed-looking setups.
  • Price return only. Dividends are excluded, and the benchmark is an ApnaFunda market-cap-weighted index of the same listed companies, not an official index.
  • Reporting lag. Fundamentals are matched on an assumed 60-day lag after the quarter end, not on real announcement dates.
  • Pools: non-financial: 98,395 company-months from 2019 companies; financial: 5,659 company-months from 108 companies. 2349 companies currently have a result; the rest are suppressed because too few comparable situations exist.

Does it work? A walk-forward check

The walk-forward check has not been run for this build, so skill is shown as not yet measured.

Disclaimer

This is history, not a forecast. These are past situations where other companies had broadly similar reported numbers and price trends. What happened to them does not tell you what will happen to any company shown. The comparison covers only 2020–2025, a single market period, and only companies still listed today. Companies that were delisted or went bankrupt are missing, which makes past outcomes look better than they were. Returns exclude dividends and are measured against an ApnaFunda-built index, not an official benchmark. Fundamentals are matched on a 60-day assumed reporting lag, not actual announcement dates. Its historical skill has not yet been measured. Past patterns may not repeat.

What else looks like this?

Companies with the most similar financial profile today, regardless of industry.

Consumer Durables
74%similar
promoter holdingP/E
FDCFDC
Health Technology
70%similar
ROCEmarket cap
VINATI ORGANICSVINATIORGA
Process Industries
66%similar
revenueP/E
Health Technology
64%similar
ROCEpromoter holding
Health Technology
64%similar
volatilityoperating margin
Consumer Non-Durables
56%similar
market capROCE
Consumer Non-Durables
53%similar
operating marginpromoter holding
Consumer Non-Durables
48%similar
volatilityrevenue

Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.

What changed?

7 events since Dec '25

  1. NovPriceVolume reached 11.3x its 50-day median on 2026-11-05; price +8.3% that day.
  2. OctPriceFell 29% from the Nov 2025 peak to the Oct 2026 low.
  3. AugPriceVolume reached 6.9x its 50-day median on 2026-08-05; price -1.4% that day.
  4. JunDividendDividend payout cut from 235% to 0% of profit.
  5. MayPriceVolume reached 5.8x its 50-day median on 2026-05-20; price +2.3% that day.
  6. MarPriceVolume reached 24.2x its 50-day median on 2026-03-06; price +1.5% that day.
  7. DecPeer rankSlipped to the 2nd quartile of Consumer Non-Durables on operating margin (from the top quartile).

Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.

Where price and fundamentals disagree, market-wide Rewind the whole market to any month

Monthly history13 months · 2025-11 to 2026-11
MonthP/ERevenue (TTM)ROEROCEDebt / Equity
2026-1126.1x₹2571 cr10.7%15.0%0.0x
2026-1024.5x₹2571 cr10.7%15.0%0.0x
2026-0925.3x₹2571 cr10.7%15.0%0.0x
2026-0828.5x₹2509 cr10.4%15.0%0.0x
2026-0726.7x₹2509 cr10.4%15.0%0.0x
2026-0629.4x₹2509 cr10.4%15.0%0.0x
2026-0534.0x₹2479 cr10.1%14.0%0.0x
2026-0435.3x₹2479 cr10.1%14.0%0.0x
2026-0332.4x₹2479 cr10.1%14.0%0.0x
2026-0231.1x₹2458 cr10.4%14.0%0.0x
2026-0131.2x₹2458 cr10.4%14.0%0.0x
2025-1233.7x₹2458 cr10.4%14.0%0.0x
2025-1133.4x₹2428 cr10.7%14.0%0.0x

Methodology and data notes

Methodology

Methodology and data notes

All figures come from public exchange prices and screener.in financial statements. Quarterly and annual results are shown from 60 days after the period end, so a month never uses a result before it would plausibly have been published. Statements are the latest versions, which may include later restatements.

Sector medians, percentiles and indices use today's listed companies in the sector (survivorship bias). Prices are adjusted for splits and bonus issues; around a corporate action the fundamentals may lag the price by up to a month, and affected sections are hidden.

The return decomposition uses price = P/E × net profit ÷ share count. The reverse DCF uses a fixed 12% cost of equity, a 10-year horizon and a 15x terminal P/E, and is an illustration only. Events, flags and twins follow fixed rules and thresholds described next to each section.

Feedback